Identity graph
Immunofoco headquarters, locations and relationships
- Legal name
- Suzhou Immunofoco Biotechnology Co., Ltd.
- Industry
- Biotechnology
- Founded
- 2020
- Phone
- +86 21 5090 7211
- Website
- immunofoco.com
- LinkedIn profile for Immunofoco
Immunofoco office locations
| City | State / region | Country | Type |
|---|---|---|---|
| Shanghai | Shanghai | China | Headquarters |
- Parent company
- No parent company recorded in GraphIQ.ai.
Verified from public filings, company websites and news · Methodology
Open in GraphIQ.aiMore Immunofoco data in GraphIQ.ai
This page shows the public record. Sign in with a work email to open the rest of the entity.
-
Technographics (available after sign-in)
Software, cloud and infrastructure in use.
-
Firmographics (available after sign-in)
Revenue, headcount, growth and industry codes.
-
Capabilities (available after sign-in)
Products, services and certifications.
-
News (available after sign-in)
Recent coverage and signals, resolved to the entity.
-
And more (available after sign-in)
Subsidiaries, people and lookalike companies.
Who uses the Immunofoco entity
-
Revenue and GTM teams
Territories, enrichment and account expansion on one resolved account.
RevOps Sales & marketing -
Industry and supply chain
Suppliers, sites and partners mapped to the right legal entity.
Industry -
Private equity and investors
Corporate family, comparable companies and deal sourcing.
Private equity -
Government and public sector
Supplier vetting, ownership and jurisdiction checks against one verified entity.
Government -
Developers and AI agents
The entity and its relationships through the REST API and MCP server.
Developers
About Immunofoco
Immunofoco is headquartered in Shanghai, Shanghai, China. Founded in 2020, the company employs approximately 75 people worldwide.
Where is Immunofoco's main office?
Immunofoco's main headquarters office is located at Jialilue Rd, Shanghai, Shanghai, China. This is the company's primary corporate address.
Immunofoco contact information
The main switchboard for Immunofoco headquarters can be reached at +86 21 5090 7211. Official website: immunofoco.com.
What does Immunofoco do?
Immunofoco is a biotechnology company that specializes in immune cell drugs for solid tumors patients.
One entity, every stage
Put Immunofoco to work across your revenue bowtie
- Target Define the market Build the account list from companies shaped like your best customers, Immunofoco included. Fingerprint search
- Cover Plan territories Immunofoco resolves to one account, so it lands in one territory, once. Territory planning
- Engage Act on timing Leadership changes, funding and M&A arrive linked to the account, not a loose headline. Signal monitoring
- Convert Close on a resolved record Inbound and closed-won attach to one CRM record, with no duplicates to merge. CRM enrichment
- Retain Ground every answer Customer teams and AI agents answer from the same entity, with a source and a date. AI agent data layer
- Expand Find the next buyer inside Follow subsidiaries and divisions to the next team that can buy. Account expansion
About the source
What is GraphIQ.ai?
A B2B identity graph. It resolves each organization into one verified entity and maps its parent and subsidiaries, employees, competitors and news signals. Revenue teams use it in the product; AI agents query it through the REST API and MCP server.
POST/api/v2/organizations/search
Immunofoco: frequently asked questions
Where is Immunofoco headquarters?
Jialilue Rd, Shanghai, Shanghai, China.
What is Immunofoco's phone number?
+86 21 5090 7211 (headquarters).
When was Immunofoco founded?
2020.
How many employees does Immunofoco have?
About 75, as of October 2026 (GraphIQ.ai estimate).
Questions about GraphIQ.ai
Is GraphIQ.ai a list of companies like a spreadsheet?
No. Each organization resolves to one verified entity linked to its parent, subsidiaries, people and signals, so Immunofoco here is the same Immunofoco in your CRM, territory plan and agent answers.
Where does this Immunofoco data come from?
Public filings, company websites and news, resolved to one entity and continuously updated.